A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization
NS Kola Srinivas, R Verma, G Pai Kulyadi… - International journal of …, 2017 - Taylor & Francis
Gefitinib is an anticancer agent which acts by inhibiting epidermal growth factor receptor
tyrosine kinase receptors. The aim of the present study was to prepare gefitinib …
tyrosine kinase receptors. The aim of the present study was to prepare gefitinib …
A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization
NSK Srinivas, R Verma… - International journal …, 2016 - pubmed.ncbi.nlm.nih.gov
Gefitinib is an anticancer agent which acts by inhibiting epidermal growth factor receptor
tyrosine kinase receptors. The aim of the present study was to prepare gefitinib …
tyrosine kinase receptors. The aim of the present study was to prepare gefitinib …
A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization
NSK Srinivas, R Verma, GP Kulyadi… - International Journal of …, 2017 - search.proquest.com
Gefitinib is an anticancer agent which acts by inhibiting epidermal growth factor receptor
tyrosine kinase receptors. The aim of the present study was to prepare gefitinib …
tyrosine kinase receptors. The aim of the present study was to prepare gefitinib …
A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization.
KS NS, R Verma, L Kumar - International Journal of …, 2016 - europepmc.org
Gefitinib is an anticancer agent which acts by inhibiting epidermal growth factor receptor
tyrosine kinase receptors. The aim of the present study was to prepare gefitinib …
tyrosine kinase receptors. The aim of the present study was to prepare gefitinib …
A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization
NSK Srinivas, R Verma, GP Kulyadi… - International Journal of …, 2017 - go.gale.com
Gefitinib is an anticancer agent which acts by inhibiting epidermal growth factor receptor
tyrosine kinase receptors. The aim of the present study was to prepare gefitinib …
tyrosine kinase receptors. The aim of the present study was to prepare gefitinib …
[HTML][HTML] A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization
NSK Srinivas, R Verma, GP Kulyadi… - International Journal of …, 2017 - ncbi.nlm.nih.gov
Gefitinib is an anticancer agent which acts by inhibiting epidermal growth factor receptor
tyrosine kinase receptors. The aim of the present study was to prepare gefitinib …
tyrosine kinase receptors. The aim of the present study was to prepare gefitinib …
A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization
NSK Srinivas, R Verma, GP Kulyadi… - International Journal of …, 2016 - dovepress.com
Gefitinib is an anticancer agent which acts by inhibiting epidermal growth factor receptor
tyrosine kinase receptors. The aim of the present study was to prepare gefitinib …
tyrosine kinase receptors. The aim of the present study was to prepare gefitinib …